Io Therapeutics, Inc.

Organization

Houston, TX, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Synthesis of tetrahydronaphthalenols and uses thereof
- Patent number 11,976,021
- Issue date May 7, 2024
- Io Therapeutics, Inc.
- Vidyasagar Vuligonda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RXR agonist salt form, polymorphs thereof, and uses thereof
- Patent number 11,919,848
- Issue date Mar 5, 2024
- Io Therapeutics, Inc.
- Vidyasagar Vuligonda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of an RXR agonist and taxanes in treating Her2+ cancers
- Patent number 11,896,558
- Issue date Feb 13, 2024
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Autoimmune disorder treatment using RXR agonists
- Patent number 11,793,781
- Issue date Oct 24, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Methods of using RARγ agonists for cancer treatment
- Patent number 11,793,835
- Issue date Oct 24, 2023
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RAR selective agonists in combination with immune modulators for ca...
- Patent number 11,786,555
- Issue date Oct 17, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Receptor subtype and function selective retinoid and rexinoid compo...
- Patent number 11,779,558
- Issue date Oct 10, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunomodulatory and differentiating function selective retinoid an...
- Patent number 11,737,996
- Issue date Aug 29, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of autoimmune diseases with combinations of RXR agonists...
- Patent number 11,690,831
- Issue date Jul 4, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Receptor subtype and function selective retinoid and rexinoid compo...
- Patent number 11,648,223
- Issue date May 16, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of CYP26-resistant RAR alpha selective agonists in the treatmen...
- Patent number 11,648,222
- Issue date May 16, 2023
- Io Therapeutics, Inc.
- Gabriel Ghiaur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Autoimmune disorder treatment using RXR agonists
- Patent number 11,576,881
- Issue date Feb 14, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Autoimmune disorder treatment using RXR agonists
- Patent number 11,547,684
- Issue date Jan 10, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of disease with esters of selective RXR agonists
- Patent number 11,517,549
- Issue date Dec 6, 2022
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Autoimmune disorder treatment using RXR agonists
- Patent number 11,246,845
- Issue date Feb 15, 2022
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Use of an RXR agonist in treating HER2+ cancers
- Patent number 11,224,583
- Issue date Jan 18, 2022
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Autoimmune disorder treatment using RXR agonists
- Patent number 11,166,927
- Issue date Nov 9, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of nervous system disorders using combinations of RXR ago...
- Patent number 11,065,219
- Issue date Jul 20, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of nervous system disorders using combinations of RXR ago...
- Patent number 10,987,330
- Issue date Apr 27, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of nervous system disorders using combinations of RXR ago...
- Patent number 10,980,759
- Issue date Apr 20, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of nervous system disorders using combinations of RXR ago...
- Patent number 10,980,760
- Issue date Apr 20, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of nervous system disorders using combinations of RXR ago...
- Patent number 10,980,761
- Issue date Apr 20, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer with specific RXR agonists
- Patent number 10,973,788
- Issue date Apr 13, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of nervous system disorders using combinations of RXR ago...
- Patent number 10,973,791
- Issue date Apr 13, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of an RXR agonist in treating HER2+ cancers
- Patent number 10,966,950
- Issue date Apr 6, 2021
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of autoimmune diseases with combinations of RXR agonists...
- Patent number 10,946,001
- Issue date Mar 16, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Autoimmune disorder treatment using RXR agonists
- Patent number 10,945,976
- Issue date Mar 16, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of CYP26-resistant RAR alpha selective agonists in the treatmen...
- Patent number 10,940,127
- Issue date Mar 9, 2021
- Io Therapeutics, Inc.
- Gabriel Ghiaur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and synthetic methods for the preparation of retinoid X r...
- Patent number 10,919,835
- Issue date Feb 16, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Receptor subtype and function selective retinoid and rexinoid compo...
- Patent number 10,881,628
- Issue date Jan 5, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF USING RARy AGONISTS FOR CANCER TREATMENT
- Publication number 20240050479
- Publication date Feb 15, 2024
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHESIS OF TETRAHYDRONAPHTHALENOLS AND USES THEREOF
- Publication number 20230416190
- Publication date Dec 28, 2023
- Io Therapeutics, Inc.
- Vidyasagar Vuligonda
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMEN...
- Publication number 20230310354
- Publication date Oct 5, 2023
- Io Therapeutics, Inc.
- Gabriel Ghiaur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RXR AGONIST SALT FORM, POLYMORPHS THEREOF, AND USES THEREOF
- Publication number 20230295069
- Publication date Sep 21, 2023
- Io Therapeutics, Inc.
- Vidyasagar Vuligonda
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF AN RXR AGONIST AND TAXANES IN TREATING HER2+ CANCERS
- Publication number 20230172872
- Publication date Jun 8, 2023
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN RXR AGONIST IN TREATING DRUG RESISTANT HER2+ CANCERS
- Publication number 20230172890
- Publication date Jun 8, 2023
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF DISEASE WITH ESTERS OF SELECTIVE RXR AGONISTS
- Publication number 20230126763
- Publication date Apr 27, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF DISEASE WITH ESTERS OF SELECTIVE RXR AGONISTS
- Publication number 20230129034
- Publication date Apr 27, 2023
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING RARy AGONISTS FOR CANCER TREATMENT
- Publication number 20230095368
- Publication date Mar 30, 2023
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF DISEASES BY CONCURRENTLY ELICITING REMYELINATION EFFEC...
- Publication number 20220370386
- Publication date Nov 24, 2022
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN RXR AGONIST IN TREATING HER2+ CANCERS
- Publication number 20220211652
- Publication date Jul 7, 2022
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMEN...
- Publication number 20220184013
- Publication date Jun 16, 2022
- Io Therapeutics, Inc.
- Gabriel Ghiaur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPO...
- Publication number 20220184012
- Publication date Jun 16, 2022
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS
- Publication number 20220151964
- Publication date May 19, 2022
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
TREATMENT OF AUTOIMMUNE DISEASES WITH COMBINATIONS OF RXR AGONISTS...
- Publication number 20220143000
- Publication date May 12, 2022
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGO...
- Publication number 20210315850
- Publication date Oct 14, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPO...
- Publication number 20210275478
- Publication date Sep 9, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS
- Publication number 20210205243
- Publication date Jul 8, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF AUTOIMMUNE DISEASES WITH COMBINATIONS OF RXR AGONISTS...
- Publication number 20210161874
- Publication date Jun 3, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND SYNTHETIC METHODS FOR THE PREPARATION OF RETINOID X R...
- Publication number 20210139404
- Publication date May 13, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN RXR AGONIST IN TREATING HER2+ CANCERS
- Publication number 20210137871
- Publication date May 13, 2021
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMEN...
- Publication number 20210137865
- Publication date May 13, 2021
- Io Therapeutics, Inc.
- Gabriel Ghiaur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMEN...
- Publication number 20210137866
- Publication date May 13, 2021
- Io Therapeutics, Inc.
- Gabriel Ghiaur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS
- Publication number 20210128503
- Publication date May 6, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS
- Publication number 20210128504
- Publication date May 6, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPO...
- Publication number 20210113507
- Publication date Apr 22, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY AND DIFFERENTIATING FUNCTION SELECTIVE RETINOID AN...
- Publication number 20210113506
- Publication date Apr 22, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RAR SELECTIVE AGONISTS IN COMBINATION WITH IMMUNE MODULATORS FOR CA...
- Publication number 20210100844
- Publication date Apr 8, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF MUSCULAR DISORDERS WITH COMBINATIONS OF RXR AGONISTS A...
- Publication number 20210077445
- Publication date Mar 18, 2021
- Io Therapeutics, Inc.
- Roshantha A. Chandraratna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN RXR AGONIST IN TREATING HER2+ CANCERS
- Publication number 20200390736
- Publication date Dec 17, 2020
- Io Therapeutics, Inc.
- Martin E. Sanders
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

NIH Research Projectlast 12 months

processing...

Count: 3

Research Projects

Information Research Project
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis...
- Application id 9319121
- Award notice date Jul 6, 2017
Information Research Project
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis...
- Application id 9201916
- Award notice date Jul 20, 2016
Information Research Project
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis...
- Application id 8714426
- Award notice date Jun 10, 2014

Io Therapeutics, Inc.

Organization

Patents Grantslast 30 patents

Synthesis of tetrahydronaphthalenols and uses thereof

RXR agonist salt form, polymorphs thereof, and uses thereof

Use of an RXR agonist and taxanes in treating Her2+ cancers

Autoimmune disorder treatment using RXR agonists

Methods of using RARγ agonists for cancer treatment

RAR selective agonists in combination with immune modulators for ca...

Receptor subtype and function selective retinoid and rexinoid compo...

Immunomodulatory and differentiating function selective retinoid an...

Treatment of autoimmune diseases with combinations of RXR agonists...

Receptor subtype and function selective retinoid and rexinoid compo...

Use of CYP26-resistant RAR alpha selective agonists in the treatmen...

Autoimmune disorder treatment using RXR agonists

Autoimmune disorder treatment using RXR agonists

Treatment of disease with esters of selective RXR agonists

Autoimmune disorder treatment using RXR agonists

Use of an RXR agonist in treating HER2+ cancers

Autoimmune disorder treatment using RXR agonists

Treatment of nervous system disorders using combinations of RXR ago...

Treatment of nervous system disorders using combinations of RXR ago...

Treatment of nervous system disorders using combinations of RXR ago...

Treatment of nervous system disorders using combinations of RXR ago...

Treatment of nervous system disorders using combinations of RXR ago...

Treatment of cancer with specific RXR agonists

Treatment of nervous system disorders using combinations of RXR ago...

Use of an RXR agonist in treating HER2+ cancers

Treatment of autoimmune diseases with combinations of RXR agonists...

Autoimmune disorder treatment using RXR agonists

Use of CYP26-resistant RAR alpha selective agonists in the treatmen...

Compounds and synthetic methods for the preparation of retinoid X r...

Receptor subtype and function selective retinoid and rexinoid compo...

Patents Applicationslast 30 patents

METHODS OF USING RARy AGONISTS FOR CANCER TREATMENT

SYNTHESIS OF TETRAHYDRONAPHTHALENOLS AND USES THEREOF

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMEN...

RXR AGONIST SALT FORM, POLYMORPHS THEREOF, AND USES THEREOF

USE OF AN RXR AGONIST AND TAXANES IN TREATING HER2+ CANCERS

USE OF AN RXR AGONIST IN TREATING DRUG RESISTANT HER2+ CANCERS

TREATMENT OF DISEASE WITH ESTERS OF SELECTIVE RXR AGONISTS

TREATMENT OF DISEASE WITH ESTERS OF SELECTIVE RXR AGONISTS

METHODS OF USING RARy AGONISTS FOR CANCER TREATMENT

TREATMENT OF DISEASES BY CONCURRENTLY ELICITING REMYELINATION EFFEC...

USE OF AN RXR AGONIST IN TREATING HER2+ CANCERS

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMEN...

RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPO...

AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS

TREATMENT OF AUTOIMMUNE DISEASES WITH COMBINATIONS OF RXR AGONISTS...

TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGO...

RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPO...

TREATMENT OF CANCER WITH SPECIFIC RXR AGONISTS

TREATMENT OF AUTOIMMUNE DISEASES WITH COMBINATIONS OF RXR AGONISTS...

COMPOUNDS AND SYNTHETIC METHODS FOR THE PREPARATION OF RETINOID X R...

USE OF AN RXR AGONIST IN TREATING HER2+ CANCERS

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMEN...

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMEN...

AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS

AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS

RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPO...

IMMUNOMODULATORY AND DIFFERENTIATING FUNCTION SELECTIVE RETINOID AN...

RAR SELECTIVE AGONISTS IN COMBINATION WITH IMMUNE MODULATORS FOR CA...

TREATMENT OF MUSCULAR DISORDERS WITH COMBINATIONS OF RXR AGONISTS A...

USE OF AN RXR AGONIST IN TREATING HER2+ CANCERS

NIH Research Projectlast 12 months

Research Projects

Development of the RXR agonist IRX4204 to treat Multiple Sclerosis...

Development of the RXR agonist IRX4204 to treat Multiple Sclerosis...

Development of the RXR agonist IRX4204 to treat Multiple Sclerosis...